HPV Becton Dickinson Gets CE Mark for At-Home Self-Collected HPV Test Indication The BD Onclarity test can now be used with samples collected at home on the firm's BD Viper and BD Cor molecular diagnostic systems. Qiagen, Inovio Expand CDx Partnership, Starting With NGS Test for Cervical Dysplasia Therapy The partners will develop a test to identify women most likely to benefit from VGX-3100, Inovio's immunotherapy to treat HPV-associated advanced cervical dysplasia. Naveris Explores New Applications for ctDNA HPV Head and Neck Cancer Test Premium The company plans to publish new data on clinical sensitivity and specificity and has initiated multiple studies investigating new use cases. Naveris Closes $17M Series A Round to Advance Virus-Related Cancer MDx Tests The company offers a blood test that detects human papillomavirus-related cancer by measuring tumor tissue-modified viral DNA using droplet digital PCR. Qiagen to Develop Companion Diagnostic for BioNTech Head, Neck Cancer Treatment The test will identify patients with squamous cell head and neck cancer caused by specific HPV infections for treatment with BioNTech's investigational BNT113. Oct 22, 2020 Summit Biolabs Commercializing Tests for Head and Neck Cancer Recurrence, COVID-19 Premium Sep 23, 2020 Becton Dickinson Submits Premarket Approval Supplement to FDA for HPV Assay Sep 20, 2020 HPV, p16 May Offer Different Prognostic Clues in Oropharyngeal Cancer, ESMO Data Reveals Premium Aug 3, 2020 Cervical Cancer Study in Ugandan Women Finds HPV-Specific Tumor DNA Methylation, Gene Expression Jul 22, 2020 BD Receives FDA Supplemental Premarket Approval for Extended Genotyping HPV MDx Jul 20, 2020 NeuMoDx Molecular Receives CE Mark for HPV Diagnostic Test Apr 22, 2020 Roche Diagnostics Q1 Sales Essentially Flat Apr 21, 2020 Roche Gets FDA Approval for HPV Test Used With Cobas 6800/8800 Platforms Mar 26, 2020 Cervicovaginal Microbiomes of HPV-Infected Women Lead To Potential Pre-Cancer Marker Mar 24, 2020 HPV Head and Neck Cancer Recurrence Test Data Adds Validation as Naveris Ramps Clinical Launch Premium Feb 6, 2020 BD Posts 2 Percent Gain in Fiscal Q1 Revenues but Lowers Guidance Jan 30, 2020 Atila Biosystems High-Throughput Isothermal HPV Test Validated in Study Premium Jan 27, 2020 QuantuMDx Raises $14M to Support Development of POC Genotyping Assay Jan 23, 2020 Viral Cancer Early Detection Efforts Making Progress Toward the Clinic Premium Dec 3, 2019 Co-Diagnostics Joint Venture Gets Clearance in India for Five MDx Tests Nov 20, 2019 Beckman Coulter, IncellDx Form Cancer Assay Promotion Agreement Nov 12, 2019 Becton Dickinson Submits HPV Assay for Expanded US Premarket Approval Oct 17, 2019 NeuMoDx, SelfScreen Collaborate to Obtain CE Marking for HPV Assay Oct 15, 2019 Enzo Biochem Fiscal Q4 Revenues Down 8 Percent Aug 30, 2019 Transcriptome-Based HPV Assay Shows Correlation With High-Grade Cytology Premium Load More Breaking News Cytosine Base Editor Enables Genome-Wide Genetic Function Screening G42 Healthcare, Seegene to Offer Mobile Molecular Diagnostic Labs in Middle East, North Africa JP Morgan, Cowen Initiate Coverage of Singular Genomics Systems Top Five Articles on GenomeWeb Last Week: Danaher, Becton Dickinson, 23andMe, and More Berry Oncology, Alibaba Health Partner to Offer Early Cancer Screening, Health Services Roche Receives FDA EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test The Scan Renewed Gain-of-Function Worries The New York Times writes that the pandemic is renewing concerns about gain-of-function research. Who's Getting the Patents? A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports. Other Uses CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2. PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.